(Q37442760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

25 January 2020

main subject

feces

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Adrian G McNicholl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Fernando Gomollon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

1 reference

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1746-1754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19363798%20AND%20SRC:MED&resulttype=core&format=json

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

25 January 2020

cites work

1 reference

Enzymes in feces: useful markers of chronic inflammatory bowel disease

21 January 2018

1 reference

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

21 January 2018

1 reference

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

C-reactive protein as a marker for inflammatory bowel disease

21 January 2018

1 reference

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

21 January 2018

1 reference

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

21 January 2018

1 reference

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease

21 January 2018

1 reference

Review of fecal biomarkers in inflammatory bowel disease

21 January 2018

1 reference

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

21 January 2018

1 reference

Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process

21 January 2018

1 reference

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

21 January 2018

1 reference

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

21 January 2018

1 reference

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

21 January 2018

1 reference

Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease.

21 January 2018

1 reference

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

21 January 2018

1 reference

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

21 January 2018

1 reference

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

21 January 2018

1 reference

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

21 January 2018

1 reference

Fecal lactoferrin: a new parameter to monitor infliximab therapy.

21 January 2018

1 reference

Recurrence of Crohn's disease after resection

21 January 2018

1 reference

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

21 January 2018

1 reference